MFN2: A Potential Drug Target and Biomarker for Neurodegenerative Disorders

Target Name: MFN2

NCBI ID: G9927

MFN2

MFN2: A Potential Drug Target and Biomarker for Neurodegenerative Disorders

Neurodegenerative diseases such as Alzheimer's, Parkinson's, and Huntington's diseases are some of the most common and debilitating conditions affecting human beings. These conditions are characterized by the progressive loss of brain cells, leading to a range of symptoms such as memory loss, cognitive decline, and progressive muscle weakness. Despite advances in medical care, there is currently no cure for these diseases, and the treatments available are often limited in their effectiveness. Therefore, there is a need for new drug targets and biomarkers to improve the treatment options for neurodegenerative disorders.

One potential drug target and biomarker for neurodegenerative disorders is MFN2 (Mitofusin-2), a gene that has been identified as a potential drug target for several neurodegenerative diseases. MFN2 is a protein that is expressed in the brain and is involved in the regulation of Mitochondria function. It has been shown to play a role in the development and progression of several neurodegenerative diseases, including Alzheimer's and Parkinson's diseases.

One of the key features of MFN2 is its role in the regulation of mitochondrial function. Mitochondria are organelles that are responsible for generating the energy that cells need to function. They are also involved in the production of neurotransmitters, including dopamine and serotonin, which are important for mood and cognitive function. MFN2 is shown to play a role in regulating the levels of these neurotransmitters in the brain, and it has been shown to contribute to the development of neurodegenerative diseases.

In addition to its role in mitochondrial function, MFN2 has also been shown to be involved in the regulation of cellular signaling pathways that are important for brain development and function. One of the most significant findings related to MFN2 is its role in the regulation of the TGF-β pathway, a pathway that is involved in the development and maintenance of neural stem cells. TGF-β is a transcription factor that is involved in the regulation of cellular signaling pathways that are important for brain development and function. MFN2 has been shown to play a role in the regulation of TGF-β activity, and this has implications for the development of neurodegenerative diseases.

Another study has shown that MFN2 is involved in the regulation of the N-methyl-D-aspartate (NMDA) receptor, a protein that is involved in the regulation of pain and neurotransmission. NMDA receptors are important for the regulation of pain perception and have MFN2 has been implicated in the development of neurodegenerative diseases. MFN2 has been shown to play a role in the regulation of NMDA receptor activity, which has implications for the development and progression of neurodegenerative diseases.

MFN2 has also been shown to be involved in the regulation of the voltage-gated potassium channels, which are involved in the regulation of ion traffic in the brain. The regulation of potassium channels is important for the maintenance of normal neurotransmission and has implications for the development and progression of neurodegenerative diseases.

In conclusion, MFN2 is a protein that has been shown to play a role in the regulation of several important cellular processes that are involved in the development and progression of neurodegenerative diseases. Therefore, it is a potential drug target and biomarker for neurodegenerative disorders. Further research is needed to fully understand the role of MFN2 in neurodegenerative diseases and to develop new treatments.

Protein Name: Mitofusin 2

Functions: Mitochondrial outer membrane GTPase that mediates mitochondrial clustering and fusion (PubMed:11181170, PubMed:11950885, PubMed:26214738, PubMed:28114303). Mitochondria are highly dynamic organelles, and their morphology is determined by the equilibrium between mitochondrial fusion and fission events (PubMed:28114303). Overexpression induces the formation of mitochondrial networks (PubMed:28114303). Membrane clustering requires GTPase activity and may involve a major rearrangement of the coiled coil domains (Probable). Plays a central role in mitochondrial metabolism and may be associated with obesity and/or apoptosis processes (By similarity). Plays an important role in the regulation of vascular smooth muscle cell proliferation (By similarity). Involved in the clearance of damaged mitochondria via selective autophagy (mitophagy) (PubMed:23620051). Is required for PRKN recruitment to dysfunctional mitochondria (PubMed:23620051). Involved in the control of unfolded protein response (UPR) upon ER stress including activation of apoptosis and autophagy during ER stress (By similarity). Acts as an upstream regulator of EIF2AK3 and suppresses EIF2AK3 activation under basal conditions (By similarity)

The "MFN2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MFN2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets